[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Gene Amplification Technologies Market, Global Outlook and Forecast 2022-2028

April 2022 | 66 pages | ID: G0F9AF99C7BDEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Gene amplification refers to a number of natural and artificial processes by which the number of copies of a gene is increased 'without a proportional increase in other genes'.

This report contains market size and forecasts of Gene Amplification Technologies in Global, including the following market information:

Global Gene Amplification Technologies Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Gene Amplification Technologies market was valued at 3710.8 million in 2021 and is projected to reach US$ 7027 million by 2028, at a CAGR of 9.6% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Polymerase Chain Reaction (PCR) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Gene Amplification Technologies include Abbott Laboratories, QIAGEN, Agilent Technologies, Bayer Corporation, Rubicon Genomics, BD, Roche Diagnostics, BioMerieux and Bio-Rad Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gene Amplification Technologies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Gene Amplification Technologies Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Gene Amplification Technologies Market Segment Percentages, by Type, 2021 (%)
  • Polymerase Chain Reaction (PCR)
  • Loop Mediated Isothermal Amplification (LAMP)
  • Other
Global Gene Amplification Technologies Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Gene Amplification Technologies Market Segment Percentages, by Application, 2021 (%)
  • Medical
  • Forensics
  • Paternity
  • Personnel Identification
  • Food safety
  • Other
Global Gene Amplification Technologies Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Gene Amplification Technologies Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Gene Amplification Technologies revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Gene Amplification Technologies revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Abbott Laboratories
  • QIAGEN
  • Agilent Technologies
  • Bayer Corporation
  • Rubicon Genomics
  • BD
  • Roche Diagnostics
  • BioMerieux
  • Bio-Rad Laboratories
  • Cepheid
  • Life Technologies
  • Takara Bio
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Gene Amplification Technologies Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Gene Amplification Technologies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GENE AMPLIFICATION TECHNOLOGIES OVERALL MARKET SIZE

2.1 Global Gene Amplification Technologies Market Size: 2021 VS 2028
2.2 Global Gene Amplification Technologies Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Gene Amplification Technologies Players in Global Market
3.2 Top Global Gene Amplification Technologies Companies Ranked by Revenue
3.3 Global Gene Amplification Technologies Revenue by Companies
3.4 Top 3 and Top 5 Gene Amplification Technologies Companies in Global Market, by Revenue in 2021
3.5 Global Companies Gene Amplification Technologies Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene Amplification Technologies Players in Global Market
  3.6.1 List of Global Tier 1 Gene Amplification Technologies Companies
  3.6.2 List of Global Tier 2 and Tier 3 Gene Amplification Technologies Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Gene Amplification Technologies Market Size Markets, 2021 & 2028
  4.1.2 Polymerase Chain Reaction (PCR)
  4.1.3 Loop Mediated Isothermal Amplification (LAMP)
  4.1.4 Other
4.2 By Type - Global Gene Amplification Technologies Revenue & Forecasts
  4.2.1 By Type - Global Gene Amplification Technologies Revenue, 2017-2022
  4.2.2 By Type - Global Gene Amplification Technologies Revenue, 2023-2028
  4.2.3 By Type - Global Gene Amplification Technologies Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Gene Amplification Technologies Market Size, 2021 & 2028
  5.1.2 Medical
  5.1.3 Forensics
  5.1.4 Paternity
  5.1.5 Personnel Identification
  5.1.6 Food safety
  5.1.7 Other
5.2 By Application - Global Gene Amplification Technologies Revenue & Forecasts
  5.2.1 By Application - Global Gene Amplification Technologies Revenue, 2017-2022
  5.2.2 By Application - Global Gene Amplification Technologies Revenue, 2023-2028
  5.2.3 By Application - Global Gene Amplification Technologies Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Gene Amplification Technologies Market Size, 2021 & 2028
6.2 By Region - Global Gene Amplification Technologies Revenue & Forecasts
  6.2.1 By Region - Global Gene Amplification Technologies Revenue, 2017-2022
  6.2.2 By Region - Global Gene Amplification Technologies Revenue, 2023-2028
  6.2.3 By Region - Global Gene Amplification Technologies Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Gene Amplification Technologies Revenue, 2017-2028
  6.3.2 US Gene Amplification Technologies Market Size, 2017-2028
  6.3.3 Canada Gene Amplification Technologies Market Size, 2017-2028
  6.3.4 Mexico Gene Amplification Technologies Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Gene Amplification Technologies Revenue, 2017-2028
  6.4.2 Germany Gene Amplification Technologies Market Size, 2017-2028
  6.4.3 France Gene Amplification Technologies Market Size, 2017-2028
  6.4.4 U.K. Gene Amplification Technologies Market Size, 2017-2028
  6.4.5 Italy Gene Amplification Technologies Market Size, 2017-2028
  6.4.6 Russia Gene Amplification Technologies Market Size, 2017-2028
  6.4.7 Nordic Countries Gene Amplification Technologies Market Size, 2017-2028
  6.4.8 Benelux Gene Amplification Technologies Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Gene Amplification Technologies Revenue, 2017-2028
  6.5.2 China Gene Amplification Technologies Market Size, 2017-2028
  6.5.3 Japan Gene Amplification Technologies Market Size, 2017-2028
  6.5.4 South Korea Gene Amplification Technologies Market Size, 2017-2028
  6.5.5 Southeast Asia Gene Amplification Technologies Market Size, 2017-2028
  6.5.6 India Gene Amplification Technologies Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Gene Amplification Technologies Revenue, 2017-2028
  6.6.2 Brazil Gene Amplification Technologies Market Size, 2017-2028
  6.6.3 Argentina Gene Amplification Technologies Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Gene Amplification Technologies Revenue, 2017-2028
  6.7.2 Turkey Gene Amplification Technologies Market Size, 2017-2028
  6.7.3 Israel Gene Amplification Technologies Market Size, 2017-2028
  6.7.4 Saudi Arabia Gene Amplification Technologies Market Size, 2017-2028
  6.7.5 UAE Gene Amplification Technologies Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott Laboratories
  7.1.1 Abbott Laboratories Corporate Summary
  7.1.2 Abbott Laboratories Business Overview
  7.1.3 Abbott Laboratories Gene Amplification Technologies Major Product Offerings
  7.1.4 Abbott Laboratories Gene Amplification Technologies Revenue in Global Market (2017-2022)
  7.1.5 Abbott Laboratories Key News
7.2 QIAGEN
  7.2.1 QIAGEN Corporate Summary
  7.2.2 QIAGEN Business Overview
  7.2.3 QIAGEN Gene Amplification Technologies Major Product Offerings
  7.2.4 QIAGEN Gene Amplification Technologies Revenue in Global Market (2017-2022)
  7.2.5 QIAGEN Key News
7.3 Agilent Technologies
  7.3.1 Agilent Technologies Corporate Summary
  7.3.2 Agilent Technologies Business Overview
  7.3.3 Agilent Technologies Gene Amplification Technologies Major Product Offerings
  7.3.4 Agilent Technologies Gene Amplification Technologies Revenue in Global Market (2017-2022)
  7.3.5 Agilent Technologies Key News
7.4 Bayer Corporation
  7.4.1 Bayer Corporation Corporate Summary
  7.4.2 Bayer Corporation Business Overview
  7.4.3 Bayer Corporation Gene Amplification Technologies Major Product Offerings
  7.4.4 Bayer Corporation Gene Amplification Technologies Revenue in Global Market (2017-2022)
  7.4.5 Bayer Corporation Key News
7.5 Rubicon Genomics
  7.5.1 Rubicon Genomics Corporate Summary
  7.5.2 Rubicon Genomics Business Overview
  7.5.3 Rubicon Genomics Gene Amplification Technologies Major Product Offerings
  7.5.4 Rubicon Genomics Gene Amplification Technologies Revenue in Global Market (2017-2022)
  7.5.5 Rubicon Genomics Key News
7.6 BD
  7.6.1 BD Corporate Summary
  7.6.2 BD Business Overview
  7.6.3 BD Gene Amplification Technologies Major Product Offerings
  7.6.4 BD Gene Amplification Technologies Revenue in Global Market (2017-2022)
  7.6.5 BD Key News
7.7 Roche Diagnostics
  7.7.1 Roche Diagnostics Corporate Summary
  7.7.2 Roche Diagnostics Business Overview
  7.7.3 Roche Diagnostics Gene Amplification Technologies Major Product Offerings
  7.7.4 Roche Diagnostics Gene Amplification Technologies Revenue in Global Market (2017-2022)
  7.7.5 Roche Diagnostics Key News
7.8 BioMerieux
  7.8.1 BioMerieux Corporate Summary
  7.8.2 BioMerieux Business Overview
  7.8.3 BioMerieux Gene Amplification Technologies Major Product Offerings
  7.8.4 BioMerieux Gene Amplification Technologies Revenue in Global Market (2017-2022)
  7.8.5 BioMerieux Key News
7.9 Bio-Rad Laboratories
  7.9.1 Bio-Rad Laboratories Corporate Summary
  7.9.2 Bio-Rad Laboratories Business Overview
  7.9.3 Bio-Rad Laboratories Gene Amplification Technologies Major Product Offerings
  7.9.4 Bio-Rad Laboratories Gene Amplification Technologies Revenue in Global Market (2017-2022)
  7.9.5 Bio-Rad Laboratories Key News
7.10 Cepheid
  7.10.1 Cepheid Corporate Summary
  7.10.2 Cepheid Business Overview
  7.10.3 Cepheid Gene Amplification Technologies Major Product Offerings
  7.10.4 Cepheid Gene Amplification Technologies Revenue in Global Market (2017-2022)
  7.10.5 Cepheid Key News
7.11 Life Technologies
  7.11.1 Life Technologies Corporate Summary
  7.11.2 Life Technologies Business Overview
  7.11.3 Life Technologies Gene Amplification Technologies Major Product Offerings
  7.11.4 Life Technologies Gene Amplification Technologies Revenue in Global Market (2017-2022)
  7.11.5 Life Technologies Key News
7.12 Takara Bio
  7.12.1 Takara Bio Corporate Summary
  7.12.2 Takara Bio Business Overview
  7.12.3 Takara Bio Gene Amplification Technologies Major Product Offerings
  7.12.4 Takara Bio Gene Amplification Technologies Revenue in Global Market (2017-2022)
  7.12.5 Takara Bio Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES

Table 1. Gene Amplification Technologies Market Opportunities & Trends in Global Market
Table 2. Gene Amplification Technologies Market Drivers in Global Market
Table 3. Gene Amplification Technologies Market Restraints in Global Market
Table 4. Key Players of Gene Amplification Technologies in Global Market
Table 5. Top Gene Amplification Technologies Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Gene Amplification Technologies Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Gene Amplification Technologies Revenue Share by Companies, 2017-2022
Table 8. Global Companies Gene Amplification Technologies Product Type
Table 9. List of Global Tier 1 Gene Amplification Technologies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gene Amplification Technologies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Gene Amplification Technologies Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Gene Amplification Technologies Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Gene Amplification Technologies Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Gene Amplification Technologies Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Gene Amplification Technologies Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Gene Amplification Technologies Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Gene Amplification Technologies Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Gene Amplification Technologies Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Gene Amplification Technologies Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Gene Amplification Technologies Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Gene Amplification Technologies Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Gene Amplification Technologies Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Gene Amplification Technologies Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Gene Amplification Technologies Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Gene Amplification Technologies Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Gene Amplification Technologies Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Gene Amplification Technologies Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Gene Amplification Technologies Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Gene Amplification Technologies Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Gene Amplification Technologies Product Offerings
Table 32. Abbott Laboratories Gene Amplification Technologies Revenue (US$, Mn), (2017-2022)
Table 33. QIAGEN Corporate Summary
Table 34. QIAGEN Gene Amplification Technologies Product Offerings
Table 35. QIAGEN Gene Amplification Technologies Revenue (US$, Mn), (2017-2022)
Table 36. Agilent Technologies Corporate Summary
Table 37. Agilent Technologies Gene Amplification Technologies Product Offerings
Table 38. Agilent Technologies Gene Amplification Technologies Revenue (US$, Mn), (2017-2022)
Table 39. Bayer Corporation Corporate Summary
Table 40. Bayer Corporation Gene Amplification Technologies Product Offerings
Table 41. Bayer Corporation Gene Amplification Technologies Revenue (US$, Mn), (2017-2022)
Table 42. Rubicon Genomics Corporate Summary
Table 43. Rubicon Genomics Gene Amplification Technologies Product Offerings
Table 44. Rubicon Genomics Gene Amplification Technologies Revenue (US$, Mn), (2017-2022)
Table 45. BD Corporate Summary
Table 46. BD Gene Amplification Technologies Product Offerings
Table 47. BD Gene Amplification Technologies Revenue (US$, Mn), (2017-2022)
Table 48. Roche Diagnostics Corporate Summary
Table 49. Roche Diagnostics Gene Amplification Technologies Product Offerings
Table 50. Roche Diagnostics Gene Amplification Technologies Revenue (US$, Mn), (2017-2022)
Table 51. BioMerieux Corporate Summary
Table 52. BioMerieux Gene Amplification Technologies Product Offerings
Table 53. BioMerieux Gene Amplification Technologies Revenue (US$, Mn), (2017-2022)
Table 54. Bio-Rad Laboratories Corporate Summary
Table 55. Bio-Rad Laboratories Gene Amplification Technologies Product Offerings
Table 56. Bio-Rad Laboratories Gene Amplification Technologies Revenue (US$, Mn), (2017-2022)
Table 57. Cepheid Corporate Summary
Table 58. Cepheid Gene Amplification Technologies Product Offerings
Table 59. Cepheid Gene Amplification Technologies Revenue (US$, Mn), (2017-2022)
Table 60. Life Technologies Corporate Summary
Table 61. Life Technologies Gene Amplification Technologies Product Offerings
Table 62. Life Technologies Gene Amplification Technologies Revenue (US$, Mn), (2017-2022)
Table 63. Takara Bio Corporate Summary
Table 64. Takara Bio Gene Amplification Technologies Product Offerings
Table 65. Takara Bio Gene Amplification Technologies Revenue (US$, Mn), (2017-2022)

LIST OF FIGURES

Figure 1. Gene Amplification Technologies Segment by Type in 2021
Figure 2. Gene Amplification Technologies Segment by Application in 2021
Figure 3. Global Gene Amplification Technologies Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Gene Amplification Technologies Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Gene Amplification Technologies Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gene Amplification Technologies Revenue in 2021
Figure 8. By Type - Global Gene Amplification Technologies Revenue Market Share, 2017-2028
Figure 9. By Application - Global Gene Amplification Technologies Revenue Market Share, 2017-2028
Figure 10. By Region - Global Gene Amplification Technologies Revenue Market Share, 2017-2028
Figure 11. By Country - North America Gene Amplification Technologies Revenue Market Share, 2017-2028
Figure 12. US Gene Amplification Technologies Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Gene Amplification Technologies Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Gene Amplification Technologies Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Gene Amplification Technologies Revenue Market Share, 2017-2028
Figure 16. Germany Gene Amplification Technologies Revenue, (US$, Mn), 2017-2028
Figure 17. France Gene Amplification Technologies Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Gene Amplification Technologies Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Gene Amplification Technologies Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Gene Amplification Technologies Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Gene Amplification Technologies Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Gene Amplification Technologies Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Gene Amplification Technologies Revenue Market Share, 2017-2028
Figure 24. China Gene Amplification Technologies Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Gene Amplification Technologies Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Gene Amplification Technologies Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Gene Amplification Technologies Revenue, (US$, Mn), 2017-2028
Figure 28. India Gene Amplification Technologies Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Gene Amplification Technologies Revenue Market Share, 2017-2028
Figure 30. Brazil Gene Amplification Technologies Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Gene Amplification Technologies Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Gene Amplification Technologies Revenue Market Share, 2017-2028
Figure 33. Turkey Gene Amplification Technologies Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Gene Amplification Technologies Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Gene Amplification Technologies Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Gene Amplification Technologies Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Gene Amplification Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. QIAGEN Gene Amplification Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Agilent Technologies Gene Amplification Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bayer Corporation Gene Amplification Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Rubicon Genomics Gene Amplification Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. BD Gene Amplification Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Roche Diagnostics Gene Amplification Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. BioMerieux Gene Amplification Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bio-Rad Laboratories Gene Amplification Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Cepheid Gene Amplification Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Life Technologies Gene Amplification Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Takara Bio Gene Amplification Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)



More Publications